Tom Ferguson

机构：The University of Western Australia, Fiona Stanley Hospital, Australian and New Zealand Urogenital and Prostate Cancer Trials Group

发表论文 67 篇 · 总被引 2923 次 · h-index 18

代表论文

• First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials (2017 · The Lancet Oncology · 被引 404)
• Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer (2023 · Journal of Clinical Oncology · 被引 349)
• Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma (2024 · New England Journal of Medicine · 被引 337)
• Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies (2018 · Clinical Colorectal Cancer · 被引 68)
• Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with renal cell carcinoma: Randomized, double-blind, phase III KEYNOTE-564 study. (2021 · Journal of Clinical Oncology · 被引 38)
• Pembrolizumab as post nephrectomy adjuvant therapy for patients with renal cell carcinoma: Results from 30-month follow-up of KEYNOTE-564. (2022 · Journal of Clinical Oncology · 被引 30)